Boulding Mark Elliott sold PTCT
January 8, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 1,286 shares of PTC Therapeutics, Inc. at $76.45 per share, a transaction worth $98.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,286
Price
$76.45
Total value
$98.3K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after113,626
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.